Blank
Hassan University
2020
International Ophthalmology
Sustained subconjunctival drug delivery systems: current trends and future perspectives
40
9
2385
2401
Springer
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran; Department of Ophthalmology, Imam Hassan University Hospital, Alborz University of Medical Sciences, Karaj, Iran
48
10.1007/s10792-020-01391-8
Animals; Biological Availability; Drug Delivery Systems; Eye; Glaucoma; Injections; bevacizumab; budesonide; carboplatin; celecoxib; cyclosporine; insulin; levofloxacin; metformin; penciclovir; prednisolone; triamcinolone acetonide; tumor necrosis factor inhibitor; anterior eye segment; blood eye barrier; clinical effectiveness; conjunctiva; conjunctival necrosis; conjunctival toxicity; cornea neovascularization; cornea toxicity; device migration; diabetic retinopathy; drug bioavailability; drug delivery system; dry eye; experimental uveitis; eye disease; eye edema; eye inflammation; eye toxicity; glaucoma; human; implant extrusion; intraocular drug administration; lipid storage; medical device complication; nonhuman; periocular drug administration; posterior eye segment; retinoblastoma; Review; subconjunctival drug administration; sustained release formulation; systematic review; target tissue; trend study; animal; bioavailability; eye; glaucoma; injection